Itepekimab Bests Placebo for Moderate-to-Severe Asthma
Incidence of events indicating loss of asthma control lower with itepekimab monotherapy in phase 2, proof-of-concept trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.